Prakiraan pendapatan perusahaan: Stoke Therapeutics Inc (STOK)

Logo perusahaan publik Stoke Therapeutics (STOK)

Stoke Therapeutics (STOK) develops unique RNA-based drugs for rare pathologies, which will grant the company exceptional pricing power. The lack of market alternatives for Dravet syndrome therapy strengthens its dominance. The sales volume forecast visualizes this trend, where 0.03 determines the current status of the parameter. Meanwhile, the company relies on external contractors for conducting clinical trials and batch production.

STOK - Prakiraan volume dodolan Stoke Therapeutics ing rentang 04.07.2022 - 15.11.2026

Ringkesan rincian data analitis Stoke Therapeutics (STOK)

Analisis komprehensif perusahaan:Stoke Therapeutics STOK
Produk merek Stoke Corp

This indicator captures market expectations for future revenue by transforming capitalization into a specific cash equivalent of projected sales. By analyzing the expected sales dynamics of Stoke Therapeutics (STOK), an investor can assess the extent to which current successes in RNA therapy for epilepsy are priced into the asset's value, allowing for a comparison between the rate of capital expenditure and the business's fundamental growth potential.

Pesaing wigati

Volume dodolan mangsa ngarep perusahaan TEM (Tempus AI)|Dodolan mangsa ngarep perusahaan Qiagen Group|Prakiraan pendapatan perusahaan Ionis Pharma IONS|RGEN - Volume dodolan mangsa ngarep perusahaan|RNA - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan CRSP (CRISPR Therapeutics AG)|Sema4 (WGS) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan RARE (Ultragenyx)|Volume dodolan mangsa ngarep perusahaan BEAM|Prakiraan volume dodolan Sarepta Corp|Prakiraan pendapatan perusahaan Twist Bioscience, Inc. (TWST)|Volume dodolan mangsa ngarep perusahaan 10x Genomics TXG|Prakiraan pendapatan perusahaan Intellia Therapeutics NTLA|BioLife Solutions Inc (BLFS) - Volume dodolan sing dikarepake perusahaan|wavelifesciences.com - Prakiraan volume dodolan|Maze Therapeutics Corp (MAZE) - Volume dodolan mangsa ngarep perusahaan|SION: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PRME|Prakiraan pendapatan perusahaan Taysha Gene Therapies|Prakiraan pendapatan perusahaan QURE (uniQure)|Prakiraan pendapatan perusahaan MeiraGTx (MGTX)|REGENXBIO Corp - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Solid Biosciences SLDB|OCGN - Volume dodolan mangsa ngarep perusahaan|pacb.com - Prakiraan volume dodolan|Benitec (BNTC) - Volume dodolan mangsa ngarep perusahaan|DSGN: Prakiraan volume dodolan|RCKT - Dodolan mangsa ngarep perusahaan|FDMT: Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan LXEO (lexeotx.com)|Prakiraan pendapatan perusahaan Korro Bio Inc. (KRRO)|Prakiraan volume pendapatan perusahaan EDIT|Prakiraan volume dodolan SLN (Silence Therapeutics PLC)|Pendapatan mangsa ngarep perusahaan PRQR|CDXS - Prakiraan pendapatan perusahaan|SGMO (Sangamo Therapeutics) - Prakiraan pendapatan perusahaan|NAUT: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan MGX|DTIL (precisionbiosciences.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GBIO (Generation Bio Co.)|Prakiraan pendapatan perusahaan Boundless Bio (BOLD)|Exicure - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan IMNN (imunon.com)|Dodolan mangsa ngarep perusahaan Phio Pharmaceuticals (PHIO)|MBIO: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan RNAZ (transcodetherapeutics.com)|Bionano Genomics, Inc. (BNGO) - Prakiraan pendapatan perusahaan|APDN - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan BLUE|Prakiraan volume dodolan immunoprecise.com|Prakiraan volume dodolan OMGA|Dodolan mangsa ngarep perusahaan Singular Genomics Corp|Regulus Therapeutics - Volume dodolan mangsa ngarep perusahaan|SYRS (Syros Pharmaceuticals) - Pendapatan sing dikarepake perusahaan|Telesis Bio Inc. - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan TCON (TRACON Pharmaceuticals Inc.)|UBX: Prakiraan volume dodolan